Framework agreement for oral anticancer medicines for Hospital Clinico San Carlos, Madrid
Open · 26 days left Spain · Medicines
| Buyer | Hospital Universitario Clinico San Carlos, Servicio Madrileno de Salud (Comunidad de Madrid) |
|---|---|
| Reference | AMPA 2026-0-349 (A/SUM-044125/2026) |
| Published | 21 October 2026 |
| Closing date | 27 November 2026, 23:59 Madrid time (CET, UTC+1) |
| Products | 4 lots: everolimus 5 mg and 10 mg tablets, nintedanib 100 mg and 150 mg capsules, nilotinib 150 mg and 200 mg capsules, pazopanib 200 mg and 400 mg tablets. Tender budget EUR 252,083 excl. VAT. |
| Notes | Electronic submission through the Comunidad de Madrid contracting portal. Status "En plazo" (open) when checked. Published 21 Oct 2026. CPV 33600000. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in Spain
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Supply of nintedanib and dalbavancin for Hospital Universitario de Fuenlabrada (Spain, 10 Nov)
- Framework agreement for subcutaneous omalizumab for Hospital Clinico San Carlos, Madrid (Spain, 16 Nov)
- Supply of linezolid 600 mg injection (Hong Kong SAR, China, 2 Nov)
- Supply of medicines for opportunistic infections (Government of Kenya) (Kenya, 3 Nov)
- Nationwide supply and distribution of adalimumab (Argentina, 3 Nov)
- Supply of ropeginterferon alfa-2b prefilled pens (Brunei, 3 Nov)
